Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B

NCT01906580 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Peg-IFNα-2a
DRUG: Entecavir

Sponsor

Beijing 302 Hospital